Similar Papers

Paper Title
Journal
Date
Author
BTK Inhibitors for the Treatment of Chronic Lymphocytic Leukemia
Paolo Strati ... Susan M O'Brien
Oncology Times | VOL. 41
Paolo Strati, et. al.Paolo Strati ... Susan M O'Brien
05 Sep 2019
Abstract CT133: Interim results of a Phase I/II trial of intratumoral CpG, local low-dose radiation, and oral ibrutinib in patients with low-grade B-cell lymphoma
Tanaya Shree ... Summer Guo
Cancer Research | VOL. 79
Tanaya Shree, et. al.Tanaya Shree ... Summer Guo
01 Jul 2019
Abstract CT133: Interim results of a Phase I/II trial of intratumoral CpG, local low-dose radiation, and oral ibrutinib in patients with low-grade B-cell lymphoma
Tanaya Shree ... Brock A Martin
-
Tanaya Shree, et. al.Tanaya Shree ... Brock A Martin
01 Jul 2019
Abstract CT542: Preliminary safety and efficacy results of KN046 in combination with KN026 in patients with locally advanced unresectable or metastatic HER2-positive solid cancer
Jifang Gong ... Baohong Guo
Cancer Research | VOL. 82
Jifang Gong, et. al.Jifang Gong ... Baohong Guo
15 Jun 2022
View more papers

More From: Transplantation and Cellular Therapy

Paper Title
Journal
Date
Author
G-CSF-primed bone marrow transplantation experience in 350 matched sibling donor grafts for Severe Thalassemia.
Rajat Kumar Agarwal ... Dr Lawrence Faulkner
Transplantation and cellular therapy | VOL. -
Rajat Kumar Agarwal, et. al.Rajat Kumar Agarwal ... Dr Lawrence Faulkner
29 Jan 2025
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-versus-Host Disease Survivorship after Hematopoietic Cell Transplantation: Part II. Organ Dysfunction and Immune Reconstitution Considerations for children with chronic GVHD after Hematopoietic Cell Transplantation.
Saldaña Bj Dávila ... K M Williams
Transplantation and cellular therapy | VOL. -
Saldaña Bj Dávila, et. al.Saldaña Bj Dávila ... K M Williams
22 Jan 2025
Prolonged Neurologic Symptoms Following Immune Effector Cell-Associated Neurotoxicity Syndrome in Patients With Large B Cell Lymphoma Treated With Chimeric Antigen Receptor-Modified T Cell Therapy.
Luke Maillie ... Daniel J Landsburg
Transplantation and cellular therapy | VOL. -
Luke Maillie, et. al.Luke Maillie ... Daniel J Landsburg
21 Jan 2025
Low Survival Due to Higher Risk of Relapse and Nonrelapse Mortality After Allogeneic HSCT in ATL Compared with AML and ALL.
Shohei Tomori ... Makoto Yoshimitsu
Transplantation and cellular therapy | VOL. -
Shohei Tomori, et. al.Shohei Tomori ... Makoto Yoshimitsu
17 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.